Schiffer CA, Anderson KC, Bennett CL, et al. Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001;19:1519–38.10.1200/JCO.2001.19.5.151911230498Search in Google Scholar
Brecher M. Technical manual. Bethesda, MD: American Association of Blood Banks, 2005:521.Search in Google Scholar
Santana JM, Dumont LJ. A flow cytometric method for detection and enumeration of low-level, residual red blood cells in platelets and mononuclear cell products. Transfusion 2006;46:966–72.10.1111/j.1537-2995.2006.00829.x16734813Search in Google Scholar
Gunson HH, Stratton F, Cooper DG, et al. Primary immunization of Rh-negative volunteers. BMJ 1970;1:593–5.10.1136/bmj.1.5696.59316996184985836Search in Google Scholar
Menitove JE. Immunoprophylaxis for D- patients receiving platelet transfusions from D- donors? Transfusion 2002;42:136–8.10.1046/j.1537-2995.2002.00074.x11896325Search in Google Scholar
Atoyebi W, Mundy N, Croxton T, Littlewood TJ, Murphy MF. Is it necessary to administer anti-D to prevent RhD immunization after the transfusion of RhD positive platelet concentrates? Br J Haematol 2000;111:980–3.10.1046/j.1365-2141.2000.02414.xSearch in Google Scholar
Lozano M, Cid J. The clinical implications of platelet transfusions associated with ABO or Rh(D) incompatibility. Transfus Med Rev 2003;17:57–68.10.1053/tmrv.2003.5000312522772Search in Google Scholar
Haspel R, Walsh L, Sloan SR. Platelet transfusion in an infant leading to formation of anti-D: implications for immunoprophylaxis. Transfusion 2004;44:747–9.10.1111/j.0041-1132.2004.03370.x15104657Search in Google Scholar
Molnar R, Johnson R, Sweat LT, Geiger TL. Absence of D alloimmunization in D- pediatric oncology patients receiving D-compatible single-donor platelets. Transfusion 2002;42:177–82.10.1046/j.1537-2995.2002.00015.x11896332Search in Google Scholar
Cid J, Ortin X, Elies E, Castella D, Panades M, Martin-Vega C. Absence of anti-D alloimmunization in hematologic patients after D-incompatible platelet transfusions. Transfusion 2002;42:173–6.10.1046/j.1537-2995.2002.00038.x11896331Search in Google Scholar
Hirose TG, Mays DA. The safety of RhIG in the prevention of haemolytic disease of the newborn. J Obstet Gynaecol 2007;27:545–57.10.1080/0144361070146994117896248Search in Google Scholar
FDA. Mercury in plasma-derived products. FDA/CBER Web site. 2004 (updated 09/09/04). Available at: http://www.fda.gov/cber/blood/mercplasma.htm. Accessed December 16, 2008.Search in Google Scholar
